Elevated NLR May Be a Feature of Pediatric Brain Cancer Patients

by Michal Yalon, Amos Toren, Amos Toren, Dina Jabarin, Edna Fadida, Shlomi Constantini, Ruty Mehrian-Shai
Published 2019-04-01

Pediatric glioblastoma cells are sensitive to drugs that inhibit eIF2α dephosphorylation and its phosphomimetic S51D variant

by Karin Eytan, Ziv Versano, Ziv Versano, Roni Oren, Jasmine Jacob-Hirsch, Jasmine Jacob-Hirsch, Moshe Leitner, Alon Harmelin, Gideon Rechavi, Gideon Rechavi, Gideon Rechavi, Amos Toren, Amos Toren, Shoshana Paglin, Michal Yalon, Michal Yalon
Published 2022-08-01

Cutaneous Adverse Events to Targeted Therapies and Immuno­therapies in Children: A Retrospective Study of 103 Patients from Two Tertiary Haemato-Oncology Referral Centres

by Ayelet Ollech, Michal Yalon, Gadi Abebe-Campino, Vered Molho-Pessach, Eve Finklestein, Hodaya Cohen, Aviv Barzilai, Shani Caspi, Shoshana Greenberger
Published 2021-07-01

A Highly Sensitive Flow Cytometric Approach to Detect Rare Antigen-Specific T Cells: Development and Comparison to Standard Monitoring Tools

by Meytal Dror Levinsky, Baruch Brenner, Michal Yalon, Zohar Levi, Zvi Livneh, Zoya Cohen, Tamar Paz-Elizur, Rachel Grossman, Zvi Ram, Ilan Volovitz
Published 2023-01-01

MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor.

by Hae Kyung Lee, Ariel Bier, Simona Cazacu, Susan Finniss, Cunli Xiang, Hodaya Twito, Laila M Poisson, Tom Mikkelsen, Shimon Slavin, Elad Jacoby, Michal Yalon, Amos Toren, Sandra A Rempel, Chaya Brodie
Published 2013-01-01

Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations.

by Michal Yalon, Liron Tuval-Kochen, David Castel, Itai Moshe, Inbal Mazal, Osher Cohen, Camila Avivi, Kineret Rosenblatt, Sarit Aviel-Ronen, Ginette Schiby, Joachim Yahalom, Ninette Amariglio, Raphael Pfeffer, Yaacov Lawrence, Amos Toren, Gideon Rechavi, Shoshana Paglin
Published 2016-01-01

Correction: Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations.

by Michal Yalon, Liron Tuval-Kochen, David Castel, Itai Moshe, Inbal Mazal, Osher Cohen, Camila Avivi, Kineret Rosenblatt, Sarit Aviel-Ronen, Ginette Schiby, Joachim Yahalom, Ninette Amariglio, Raphael Pfeffer, Yaacov R Lawrence, Amos Toren, Gideon Rechavi, Shoshana Paglin
Published 2016-01-01